Submit Article
Back to Journal

SM Case Reports

Erlotinib Induced Ischemic Colitis

[ ISSN : 2473-0688 ]

Abstract
Details

Received: 16-Jun-2016

Accepted: 15-Jul-2016

Published: 29-Jul-2016

Case Report | Volume 2 - Issue 3 | Article DOI :

Download PDF

Rachid Tanz¹, Tarik El Adddioui³, Mohammed Reda Khmamouch¹, Rachida Saouab⁴, Tarik Mahfoud¹, Bazine Aziz¹, Hassan Errihani², and Mohamed Ichou¹*

¹ Department of Medical Oncology, Academic Military Hospital Mohamed V, Rabat, Morocco
² National Institute of Oncology, Rabat, Morocco
³ Department of Gastroenterology, Academic Military Hospital Mohamed V, Rabat, Morocco
? Department of Radiology, Academic Military Hospital Mohamed V, Rabat, Morocco

Corresponding Author:

Rachid Tanz, Department of Medical Oncology, Academic Military Hospital Mohamed V, Rabat, Morocco, Email: tanz.rachid@gmail.com

Abstract

Ischemic Colitis (IC) is a clinical entity that includes all secondary lesions due to circulatory anoxia of the wall of the colon and/or rectum. This complication may occur in connection with the use of many drugs. Rare forms were described in combination with chemotherapy are rather secondary to neutropenia than to chemotherapy itself. Ischemic colitis induced by Erlotinib use is an exceptional form. We describe in this report a case of ischemic colitis during treatment with Erlotinib.

Citation

Tanz R, Adddioui TE, Khmamouch MR, Saouab R, Mahfoud T, Aziz B, et al. Erlotinib Induced Ischemic Colitis. SM J Case Rep. 2016; 2(3): 1031.